\
&
Contact us
\
&
Contact us
This was 2 months ago
LocationOnline
ProgrammesThe Belgium National Contact Points (NCPs) for Health are organising an online webinar to help stakeholders prepare for the Cluster Health and Mission Cancer 2025 calls in the upcoming Horizon Europe Work Programme 2025 (foreseen to be published in April).
The objectives of the webinar are:
The event is free but registration is mandatory. Our target audience for this event is limited to stakeholders interested to participate in Horizon Europe and located in Belgium.
The organiser reserves the right to decline any registration that does not fit the target of this event. Please note, that consultants are not allowed to participate in this event, except, if they demonstrate they are involved in consortiums as beneficiaries.
Registration is now open here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Climate, Energy, Mobility EIC EIE
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
